Vice President
chris.pashos@unitedbiosource.com
Chris L. Pashos, PhD is a Vice President at United BioSource Corporation. One of his primary focus areas is to ensure that the breadth and depth of UBC’s expertise is brought to bear to fully meet the market access needs of our clients. This mandate continues the scope of his activities at Abt Bio-Pharma Solutions (ABS), which was recently acquired by UBC. Dr. Pashos works with other UBC leaders to design and implement collaborations internationally with clinicians, researchers, and policymakers to assess the use, outcomes, and value of medicines, medical devices, biotechnology processes, and other health care products and services.
His work enables sponsors to understand the comprehensive value – both the benefits and the risks – of products and services, and to communicate it to multiple provider and policy audiences, thereby promoting optimal access to appropriate care. Specifically, Dr. Pashos has designed and implemented prospective observational studies, such as patient registries, involving hundreds of thousands of patients in a variety of clinical indications. His experience also extends to analyses of global databases; interactive clinical-economic models to present outcomes of therapeutic alternatives in international markets; and the development and use of survey instruments to obtain data on use of health care services and on the clinical, economic, and health-related quality of life outcomes of that care. Although Dr. Pashos has worked in many therapeutic areas, he has particularly extensive experience in oncology, urology and cardiology. Having published in leading medical journals and lectured on the quality, cost, and value of health care, Dr. Pashos serves on editorial boards of two prominent journals, Value in Health and Journal of Medical Economics. He is a recipient of the Distinguished Service Award bestowed by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). In ISPOR, he has served in a variety of leadership positions over many years, including ISPOR President for 2008-2009.
Before joining Abt Associates in 1995, he was on the faculty of the Harvard Medical School and managed the Harvard heart attack Patient Outcomes Research Team (PORT), one of the first four PORTs funded by the United States government to study the quality of health care. He also helped to create and direct the Harvard Medical School Bridges Program, which brought together national policymakers, academic experts, and private decision makers to discuss critical health care issues. Dr. Pashos holds a PhD and MPP in Public Policy from Harvard University and a B.S. with Distinction from the United States Naval Academy.